Childrens Center For Digestive Healthcare

Atlanta, Georgia 30342

7 studies enrolling now · 29 studies all time

What they study most

Arthritis, Juvenile, Arthritis, Psoriatic, Asthma, Colic, Colitis, Ulcerative, Colonoscopy, Congenital Sucrase-isomaltase Deficiency (CSID), Crohn Disease, Crohn's Disease, Crohn's Disease (CD), Crohns Disease, Eosinophilic Esophagitis

Studies at this site

• A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants — Recruiting now
• A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Recruiting now
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) — Recruiting now
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Completed
• Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Completed
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) — Completed
• Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA — Available (expanded access)
• An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE) — Completed
• A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved — Completed
• Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE) — Stopped early
• Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance — Completed
• Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease — Completed
• Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis — Completed
• OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension — Completed
• Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy — Completed
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) — Completed
• Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease. — Completed
• Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS) — Completed
• Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects — Completed
• Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis — Completed
• Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis — Completed
• Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years — Completed
• Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only — Completed
• A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. — Status unconfirmed